Synchrony Financial filings document the regulatory record of a consumer finance company with common stock and preferred depositary shares listed on the New York Stock Exchange. Its Form 8-K reports include quarterly earnings releases, financial data supplements, presentations and monthly charge-off and delinquency statistics tied to the company’s credit portfolio.
The company’s proxy materials cover annual meeting matters, director elections, auditor ratification and advisory executive compensation votes. Other filings describe capital-structure activity, including public debt offerings under shelf registration statements, senior note indenture terms, preferred stock series and related exhibits.
Synchrony Financial (symbol: SYF) is the issuer of record for a Form 4 filing submitted to the SEC.
Synchrony Financial (SYF) reported that director Alves Paget Leonard acquired 157 dividend equivalent units on August 17, 2026. These units were accrued as dividends on previously granted restricted stock units and deferred stock units under the company’s long-term incentive and director deferred compensation plans. Following this award, Leonard directly holds 52,534 dividend equivalent units, each economically equivalent to one share of Synchrony Financial common stock; the balance was also adjusted for rounding of fractional shares over time.
Synchrony Financial (SYF) director Arthur W. Coviello Jr. reported acquisitions on August 17, 2026. He received 14 Dividend Equivalent Units tied to existing restricted stock units, each economically equal to one SYF share, and acquired 11 common shares through a broker dividend reinvestment plan, bringing his directly held common shares to 26,166.
Synchrony Financial (SYF) reported that EVP and CFO Brian J. Wenzel Sr. acquired 272 dividend equivalent units on August 17, 2026. These units were accrued as dividends on common shares underlying his restricted stock units and are economically equivalent to Synchrony common stock. Following this award, his directly held dividend equivalent and related non-derivative units total 64,763, and the new units will vest and settle on the same schedule and terms as the underlying restricted stock units.
Synchrony Financial (symbol: SYF) is the issuer of record for a Form 4 filing submitted to the SEC.
Synchrony Financial executive Alberto Casellas, EVP and CEO–Health & Wellness, exercised 5,456 employee stock options for common stock at an exercise price of $33.53 per share on August 13, 2026, then sold the resulting 5,456 common shares at $80.00 per share in a market transaction.
The option exercise reduced his reported option position from a 2018 grant to 5,455 options remaining. All reported trades were made under a Rule 10b5-1 trading plan adopted on October 27, 2025.
Synchrony Financial furnished monthly charge-off and delinquency statistics for its loan portfolio for the thirteen months ended July 31, 2026. Period-end loan receivables were $102.6 billion at July 31, 2026, with average loan receivables of $101.9 billion for that month.
For July 2026, the 30+ delinquency rate was 4.2%, the reported net charge-off rate was 4.7%, and the adjusted net charge-off rate including a 0.2 percentage point recovery adjustment was 4.9%. Consumer credit card loan receivables represented greater than 90% of total period-end loan receivables at July 31, 2026. Synchrony states it plans to continue furnishing these portfolio quality statistics monthly.
Capital World Investors, a division of Capital Research and Management Company and related investment management entities, reports beneficial ownership of 18,956,052 shares of Synchrony Financial common stock. This represents 5.6% of the 336,951,336 shares believed to be outstanding as of the report. Capital World Investors has sole voting and sole dispositive power over all 18,956,052 shares, with no shared voting or dispositive power disclosed. The filing is signed by Timothy J. Moon, Vice President and Senior Counsel of Capital Research and Management Company, dated August 11, 2026.
Synchrony Financial officer Amy Tiliakos reported a tax-withholding disposition of 1,738 shares of common stock on July 31, 2026. The company automatically withheld these shares at $75.79 per share to pay her tax liability on vesting restricted stock units, leaving her with 19,900 shares held directly; no investment decision was involved.